depression
DEPRESSION
Treatment Guideline Chart

Depression is a mood disorder wherein the patient has a pervasive sad mood or loss of interest in most activities for at least 2 weeks.

It can cause significant distress and impairment. It is also a chronic, episodic and relapsing syndrome.

Treatment can be by psychotherapy alone, pharmacotherapy alone or psychotherapy combined with pharmacological therapy.

Depression References

  1. Duloxetine (Cymbalta): a new SNRI for depression. Med Lett Drugs Ther. 2004 Oct;46(1193):81-82. PMID: 15480298
  2. Ferguson JM. Depression: diagnosis and management for primary care physicians. J Clin Psychiatry. 2000 Oct;2(5):173-178
  3. Depont F, Rambelomanana S, Le Puil S, et al. Antidepressants: psychiatrists' opinions and clinical practice [abstract]. Acta Psychiatr Scan. 2003 Jul;108(1):24-31. PMID: 12807374
  4. Czeh B, Michaelis T, Watanabe T, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA. 2001 Oct;98(22):12796-12801. PMID: 11675510
  5. Kent JM. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet. 2000 Mar;355(9207):911-918. PMID: 10752718
  6. Kasper S, Olié JP. A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression [abstract]. Eur Psychiatry. 2002 Jul;17(Suppl 3):331-340. PMID: 15177089
  7. Whooley MA, Simon GE. Managing depression in medical outpatients. N Engl J Med. 2000 Dec;343(26):1942-4950. PMID: 11136266
  8. Waintraub L, Septein L, Azoulay P. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine [abstract]. CNS Drugs. 2002;16(1):65-75. PMID: 11772119
  9. Sonawalla S, Chakraborty N, Parikh R. Treatment of major depression and anxiety with the selective serotonin re-uptake enhancer tianeptine in the outpatient psychiatric care setting of India. J Indian Med Assoc. 2003 Feb;101(2):116-117,124. PMID: 12841497
  10. Rush AJ. Mood disorders: treatment of depression. In: Sadock BJ, et al. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2009
  11. MedWorm http://www.medworm.com/rss/index.php/Psychiatry/172/ www.medworm.com/rss/medicalfeeds/specialities/Psychiatry-News.xml
  12. Ministry of Health Singapore. Depression. MOH (Singapore). http://www.moh.gov.sg. Mar 2004
  13. Institute for Clinical Systems Improvement (ICSI). Major depression in adults in primary care. http://bit.ly/Depr0512. May 2012.
  14. Institute for Clinical Systems Improvement (ICSI). Health care guideline: major depression in adults for mental health care providers. http://www.icsi.org. 2002.
  15. National Institute of Mental Health. Depression. http://www.nimh.gov. 2002.
  16. National Collaborating Centre for Mental Health. The treatment and management of depression in adults. NICE. http://www.nice.org.uk. Oct 2009. Accessed 14 Jan 2011.
  17. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Psychiatryonline. http://psychiatryonline.org. Oct 2010.
  18. American Psychiatric Association. Depressive disorders. In: Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013:155-188.
  19. Bauer M, Pfennig A, Severus E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry. 2013 Jul;14(5):334-385. doi: 10.3109/15622975.2013.804195. PMID: 23879318
  20. Bauer M, Severus E, Kohler S, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015. World J Biol Psychiatry. 2015 Feb;16(2):76-95. doi: 10.3109/15622975.2014.1001786. PMID: 25677972
  21. Trangle M, Gursky J, Haight R, et al. Adult depression in primary care. Institute for Clinical Systems Improvement (ICSI). http://www.icsi.org. Mar 2016.
  22. Kennedy SH, Lam RW, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry. 2016 Sep;61(9):540-560. doi: 10.1177/0706743716659417. Accessed 10 May 2017. PMID: 27486148
  23. Parikh SV, Quilty LC, Ravitz P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2. psychological treatments. Can J Psychiatry. 2016 Sep;61(9):524-539. doi: 10.1177/0706743716659418. PMID: 27486150
  24. Chapman AL. Dialectal behavior therapy. Psychiatry (Edgmont). 2006 Sep;3(9):62-68. http://www.ncbi.nlm.nih.gov. PMID: 20975829
  25. Gitlin M. Unipolar depression in adults: treatment with lithium. UpToDate. https://www.uptodate.com. 14 Oct 2020.
  26. Hirsch M, Birnbaum R. Atypical antidepressants: pharmacology, administration, and side effects. UpToDate. https://www.uptodate.com. 04 Dec 2020. Accessed 18 Dec 2020.
  27. Hirsch M, Birnbaum R. Tricyclic and tetracyclic drugs: pharmacology, administration, and side effects. UpToDate. https://www.uptodate.com. 03 Dec 2020. Accessed 18 Dec 2020.
  28. National Institute for Health and Care Excellence. Implanted vagus nerve stimulation for treatment-resistant depression. NICE. https://www.nice.org.uk. 12 Aug 2020.
  29. National Institute for Health and Care Excellence. Depression in children and young people: identification and management. NICE. https://www.nice.org.uk. 25 Jun 2019.
  30. Substance Abuse and Mental Health Services Administration. Impact of the DSM-IV to DSM-5 changes on the national survey on drug use and health [Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration (US). Jun 2016 . Accessed 15 Oct 2020.
  31. Thase MT, Connolly KR. Ketamine and esketamine for treating unipolar depression in adults: administration, efficacy, and adverse effects. UpToDate. https://www.uptodate.com. 26 Aug 2020.
  32. Thase MT, Connolly KR. Unipolar depression in adults: choosing treatment for resistant depression. UpToDate. https://www.uptodate.com. 14 Nov 2020. Accessed 18 Dec 2020.
  33. Williams J, Nieuwsma J. Screening for depression in adults. UpToDate. https://www.uptodate.com. 26 Jun 2020. Accessed 18 Dec 2020.
  34. Baldwin D. Generalized anxiety disorder in adults: epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis. UpToDate. www.uptodate.com. 3 Apr 2018. Accessed 21 Oct 2020.
  35. Ministry of Health Malaysia. Management of major depressive disorder (second edition). MOH Malaysia. https://www.moh.gov.my. Jun 2019. Accessed 05 Feb 2021 .
  36. Anxiety and Depression Association of America. Clinical practice review for major depressive disorder. ADAA. https://www.adaa.org. Nov 2020.
  37. Lyness JM. Unipolar depression in adults: assessment and diagnosis. UpToDate. https://www.uptodate.com. 16 Sep 2019. Accessed 18 Dec 2020.
  38. McQuaid JR, Lin EH, Barber JP, et al. Clinical practice guideline for the treatment of depression across three age cohorts American Psychological Association guideline development panel for the treatment of depressive disorders. American Psychology Association. https://www.apa.org. Feb 2019.
  39. Milev RV, Giacobbe P, Kennedy SH, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. Neurostimulation treatments. Can J Psychiatry. 2016 Sep;61(9):561-575. doi: 10.1177/0706743716660033. Accessed 29 May 2019. PMID: 27486154
  40. Simon G, Rush AJ. Unipolar major depression in adults: choosing initial treatment. UpToDate. https://www.uptodate.com. 18 Nov 2020. Accessed 18 Dec 2020.
  41. Chan JWY, Lam SP, Li SX, et al. Adjunctive bright light treatment with gradual advance in unipolar major depressive disorder with evening chronotype - a randomized controlled trial. Psychol Med. 2020 Sep;14:1-10. doi: 10.1017/S0033291720003232. PMID: 32924897
  42. Cheung AH, Zuckerbrot RA, Jensen PS, et al. Guidelines for adolescent depression in primary care (GLAD-PC): part II. Treatment and ongoing management. Pediatrics. 2018 Mar;14(3):e20174082. doi: 10.1542/peds.2017-4082.
  43. Gitlin M. Unipolar depression in adults and initial treatment: investigational and nonstandard approaches. UpToDate. https://ww.uptodate.com/. 03 Jan 2020.
  44. Gottlieb JF, Benedetti F, Geoffroy PA, et al. The chronotherapeutic treatment of bipolar disorders: a systematic review and practice recommendations from the ISBD task force on chronotherapy and chronobiology. Bipolar Disord. 2019 Dec;21(8):741-773. doi: 10.1111/bdi.12847. PMID: 31609530
  45. Malhi GS, Bell E, Bassett D, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian & New Zealand Journal of Psychiatry. 2021;55(1):7-117. doi: 10.1177/0004867420979353.
  46. Wirz-Justice A, Benedetti F, Berger M, et al. Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med. 2005 Jul;35(7):939-944. doi: 10.1017/s003329170500437x. PMID: 16045060
  47. Department of Veterans Affairs, Department of Defense. VA/DoD clinical practice guideline for the management of major depressive disorder. http://www.healthquality.va.gov. Apr 2016.
  48. Nelson C. Unipolar depression in adults: treatment with second-generation antipsychotics. UpToDate. https://www.uptodate.com. 27 Aug 2020.
  49. Rush AJ. Unipolar major depression in adults: choosing initial treatment. UpToDate. https://www.uptodate.com. 18 Nov 2020.
Editor's Recommendations
Special Reports